Zacks Small Cap Has Pessimistic View of ARWR FY2025 Earnings
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Analysts at Zacks Small Cap dropped their FY2025 earnings per share (EPS) estimates for Arrowhead Pharmaceuticals in a research note issued to investors on Tuesday, September 2nd. Zacks Small Cap analyst D. Bautz now forecasts that the biotechnology company will post earnings per share of ($0.07) for […]
More Stories
Treasury, IRS Propose Rules for 1 Percent Remittance Tax on Some Money Sent to Foreign Countries
By Naveen Athrappully The Internal Revenue Service and the Department of the Treasury proposed regulations on Friday regarding the new...
Hezbollah Leader Says Group Would Continue to Fight Israel After Strikes
By Jack Phillips The leader of Lebanese terrorist organization Hezbollah has said that his group would continue to fight Israel,...
IBM to Pay $17 Million to Settle Allegations of Discrimination
By Jacki Thrapp IBM will pay millions of dollars to resolve allegations that it failed to comply with anti-discrimination requirements...
Trump Says US ‘Loading up the Ships’ Ahead of Iran Talks, Signals Military Option If Diplomacy Fails
By Tom Ozimek President Donald Trump said the United States is preparing military options if negotiations with Iran fail to...
Artemis II Mission Ends With Splashdown Off San Diego
By T.J. Muscaro HOUSTON—Humanity’s first adventure to the moon in more than 50 years is complete. Artemis II, NASA’s 10-day...
Trump Warns Iran Has ‘No Cards’ Except Strait of Hormuz in Peace Talks
By Jack Phillips President Donald Trump on Friday said that the Iranian regime has very few negotiating options ahead of...